Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Acumen Pharmaceuticals (NASDAQ:ABOS) through any online brokerage.
Other companies in Acumen Pharmaceuticals’s space includes: Connect Biopharma Holdings Ltd (NASDAQ:CNTB), Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL), Atossa Therapeutics Inc (NASDAQ:ATOS), Fate Therapeutics Inc (NASDAQ:FATE) and Whitehawk Therapeutics Inc (NASDAQ:WHWK).
Acumen Pharmaceuticals has a consensus price target of $8.50.
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $2.14 last updated December 12, 2025 at 2:08 PM EST.
There are no upcoming dividends for Acumen Pharmaceuticals.
Acumen Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Acumen Pharmaceuticals.
Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.